Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12116638 Estrogen receptor mutations and uses thereof

Patent 12116638 was granted and assigned to Foundation Medicine on October, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Foundation Medicine

Current Assignee

Foundation Medicine

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

121166380

Patent Inventor Names

Gary Palmer0

Garrett Michael Frampton0

Doron Lipson0

Vincent A. Miller0

Philip James Stephens0

Roman Yelensky0

Maureen T. Cronin0

Jeffrey S. Ross0

Date of Patent

October 15, 2024

Patent Application Number

176737180

Date Filed

February 16, 2022

Patent Citations

‌

US Patent 11286532 Estrogen receptor mutations and uses thereof

‌

US Patent 7244567 Double ended sequencing

‌

US Patent 10093983 Estrogen receptor mutations and uses thereof

Patent Primary Examiner

CPC Code

Patent abstract

Novel mutant ESR1 molecules and uses are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12116638 Estrogen receptor mutations and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API